We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

92 hedge funds and large institutions have $134M invested in Calithera Biosciences, Inc in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

575% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 4

174% more call options, than puts

Call options by funds: $444K | Put options by funds: $162K

125% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 16

30% more funds holding

Funds holding: 71 → 92 (+21)

11% less capital invested

Capital invested by funds: $150M → $134M (-$16M)

Holders
92
Holders Change
+21
Holders Change %
+29.58%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
27
Increased
36
Reduced
16
Closed
4
Calls
$444K
Puts
$162K
Net Calls
+$282K
Net Calls Change
-$1.1M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$21.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$11M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$9.75M
4
CH
CVI Holdings
Delaware
+$4.79M
5
SI
Sofinnova Investments
California
+$3.01M

Top Sellers

Rank Fund Capital Flow
1
AA
ALPS Advisors
Colorado
-$621K
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$608K
3
OAM
Oxford Asset Management
United Kingdom
-$474K
4
SIM
Spark Investment Management
New York
-$218K
5
AQR Capital Management
AQR Capital Management
Connecticut
-$149K
Name Holding Trade Value Shares
Change 		Change in
Stake
FSA
26
Franklin Street Advisors
North Carolina
$439K +$170K +1,500 +36%
Tudor Investment Corp
27
Tudor Investment Corp
Connecticut
$388K +$564K +4,970 New
Jacobs Levy Equity Management
28
Jacobs Levy Equity Management
New Jersey
$379K +$180K +1,583 +48%
Prudential Financial
29
Prudential Financial
New Jersey
$378K -$129K -1,138 -19%
LCM
30
Laurion Capital Management
New York
$375K +$545K +4,805 New
Wells Fargo
31
Wells Fargo
California
$370K +$133K +1,168 +33%
Charles Schwab
32
Charles Schwab
California
$327K +$37.1K +327 +8%
Two Sigma Investments
33
Two Sigma Investments
New York
$319K +$370K +3,262 +394%
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
$317K +$137K +1,206 +42%
Barclays
35
Barclays
United Kingdom
$283K +$303K +2,672 +281%
CAM
36
ClariVest Asset Management
California
$258K -$3.97K -35 -1%
Bank of America
37
Bank of America
North Carolina
$249K -$78.3K -690 -18%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$239K +$163K +1,440 +88%
MF
39
Magnetar Financial
Illinois
$232K +$337K +2,973 New
T. Rowe Price Associates
40
T. Rowe Price Associates
Maryland
$220K +$567 +5 +0.2%
SSA
41
Schonfeld Strategic Advisors
New York
$214K +$311K +2,741 New
USAA
42
United Services Automobile Association
Texas
$206K +$2.5K +22 +0.8%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$200K – – –
HP
44
Hikari Power
Japan
$195K – – –
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$192K +$11.2K +99 +4%
AllianceBernstein
46
AllianceBernstein
Tennessee
$181K +$90.2K +795 +52%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$165K +$5.11K +45 +2%
Walleye Trading
48
Walleye Trading
New York
$154K +$156K +1,371 +225%
Walleye Capital
49
Walleye Capital
New York
$146K +$212K +1,870 New
Squarepoint
50
Squarepoint
New York
$138K +$200K +1,765 New
1
2
3 4

CALA Hedge Fund Activity: Q2 2019 in Review

92 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2019, worth a combined $134M — down 11% from $150M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CALA positions and 4 closed out — a net gain of 23 holders — while 36 added to existing stakes and 16 trimmed.

The largest buyer was BVF Inc, adding an estimated $21.2M. The largest seller was ALPS Advisors, exiting entirely with an estimated $621K sold.

  • 92 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2019, up from 71 in Q1 2019.
  • Funds reported $134M of Calithera Biosciences, Inc stock for Q2 2019, down 11% quarter-over-quarter.
  • 27 funds opened new Calithera Biosciences, Inc positions in Q2 2019 and 4 closed out, a net change of +23 holders.
  • The largest Calithera Biosciences, Inc buyer in Q2 2019 was BVF Inc, an estimated $21.2M added.
  • The largest Calithera Biosciences, Inc seller in Q2 2019 was ALPS Advisors, an estimated $621K sold.

Based on aggregated 13F filings for Q2 2019.